Download PDF
The Journal of Hip Surgery 2023; 07(03): 117-125
DOI: 10.1055/s-0043-1771245
Original Article

Clinical Performance and Outcomes of an Injectable Bone Graft Substitute Following Core Decompression during the Treatment of Osteonecrosis of the Femoral Head

Kara McConaghy
1   Case Western Reserve University School of Medicine, Cleveland, Ohio
,
Erika L. Louiselle
2   Stryker Corporation, Kalamazoo, Michigan
,
Ashley D. Knight
2   Stryker Corporation, Kalamazoo, Michigan
,
Pedro J. Rullán
3   Department of Orthopedic Surgery, Cleveland Clinic, Cleveland, Ohio
,
Rebecca A. Hortensius
2   Stryker Corporation, Kalamazoo, Michigan
,
David A. Fitch
2   Stryker Corporation, Kalamazoo, Michigan
,
Nicolas S. Piuzzi
3   Department of Orthopedic Surgery, Cleveland Clinic, Cleveland, Ohio
4   Department of Biomedical Engineering, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio
› Author Affiliations Funding This manuscript was prepared with the financial support of Stryker Corporation. Dr. Nicolas Piuzzi is a paid consultant for Stryker Corporation. Erika Louiselle, Ashley Knight, Rebecca Hortensius, and David Fitch are paid employees of Stryker Corporation.
› Further Information
    Permissions and Reprints

Abstract

Osteonecrosis of the femoral head (ONFH) can be challenging to manage, as it primarily affects younger adult patients. Hip preservation is preferred in this population, and there is a heightened focus on treatment strategies such as biologic adjuvants and bone grafting. Therefore, the objective of this systematic literature review was to evaluate the clinical performance of a commercially available injectable bone graft substitute (calcium sulfate [CaSO4]/calcium phosphate [CaPO4]; Pro-Dense, Wright Medical Technology Inc., Memphis, TN) following core decompression for the management of ONFH. Specifically, we aimed to examine (1) patient-reported outcomes, (2) progression of disease, (3) rate of revision, and (4) complications. A systematic literature review was performed in accordance with the Preferred Reporting Items for Systematic Review and Meta-Analyses, using PubMed, Google Scholar, and Cochrane Library in July 2020 (gap search conducted in March 2022). The review included all clinical studies, published in English, on the use of an injectable bone graft substitute in ONFH-related procedures since 2007. Meta-analysis was conducted on Harris Hip Score (HHS), Visual Analog Scale (VAS), progression of disease, rate of revision, and complications. Nine studies were identified, with a total of 390 subjects ranging in age from 15 to 70 (weighted mean = 40.4) years old, with a weighted mean follow-up time of 37.1 months. Weighted mean improvement in HHS was +17.5 points (n = 296 procedures), while weighted mean improvement in VAS score was –3.0 points (n = 188 procedures). Overall weighted progression of disease for all patients was 6.1% (n = 17.9), including studies reporting precollapse (5.9%; n = 9.1/155) and/or postcollapse (9.91%; n = 16/162) lesions. Overall weighted revision rate was 2.9% (n = 11.5/390), including studies reporting precollapse (3.2%; n = 7.7/239) and/or postcollapse (4.3%; n = 8.2/191) lesions. The minor complication rate was 1.02% (n = 3/293), with no major complications reported. Clinical evidence on injectable CaSO4/CaPO4 bone graft substitute supports an acceptable benefit–risk profile, including safe real-world use since 2007, following core decompression for the treatment of ONFH.

Keywords

hip preservation - osteonecrosis of the femoral head - bone grafting - PRO-DENSE - outcomes


Publication History

Received: 02 August 2022

Accepted: 17 May 2023

Article published online:
21 August 2023

© 2023. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Moya-Angeler J, Gianakos AL, Villa JC, Ni A, Lane JM. Current concepts on osteonecrosis of the femoral head. World J Orthop 2015; 6 (08) 590-601
    CrossrefPubMedGoogle Scholar
  • 2 Sodhi N, Anis HK, Coste M, Piuzzi NS, Jones LC, Mont MA. Thirty-day complications in osteonecrosis patients following total hip arthroplasty. J Arthroplasty 2020; 35 (08) 2136-2143
    CrossrefPubMedGoogle Scholar
  • 3 Shah KN, Racine J, Jones LC, Aaron RK. Pathophysiology and risk factors for osteonecrosis. Curr Rev Musculoskelet Med 2015; 8 (03) 201-209
    CrossrefPubMedGoogle Scholar
  • 4 Mont MA, Salem HS, Piuzzi NS, Goodman SB, Jones LC. Nontraumatic osteonecrosis of the femoral head: where do we stand today?: a 5-year update. J Bone Joint Surg Am 2020; 102 (12) 1084-1099
    CrossrefPubMedGoogle Scholar
  • 5 Barney J, Piuzzi NS, Akhondi H. Femoral Head Avascular Necrosis. Treasure Island, FL: StatPearls Publishing; 2022
    Google Scholar
  • 6 Landgraeber S, Warwas S, Claßen T, Jäger M. Modifications to advanced Core decompression for treatment of avascular necrosis of the femoral head. BMC Musculoskelet Disord 2017; 18 (01) 479
    CrossrefPubMedGoogle Scholar
  • 7 Piuzzi NS, Chahla J, Schrock JB. et al. Evidence for the use of cell-based therapy for the treatment of osteonecrosis of the femoral head: a systematic review of the literature. J Arthroplasty 2017; 32 (05) 1698-1708
    CrossrefPubMedGoogle Scholar
  • 8 Chughtai M, Piuzzi NS, Khlopas A, Jones LC, Goodman SB, Mont MA. An evidence-based guide to the treatment of osteonecrosis of the femoral head. Bone Joint J 2017; 99-B (10) 1267-1279
    CrossrefPubMedGoogle Scholar
  • 9 Sionek A, Czwojdziński A, Kowalczewski J. et al. Hip osteonecroses treated with calcium sulfate-calcium phosphate bone graft substitute have different results according to the cause of osteonecrosis: alcohol abuse or corticosteroid-induced. Int Orthop 2018; 42 (07) 1491-1498
    CrossrefPubMedGoogle Scholar
  • 10 Piuzzi NS, Chahla J, Jiandong H. et al. Analysis of cell therapies used in clinical trials for the treatment of osteonecrosis of the femoral head: a systematic review of the literature. J Arthroplasty 2017; 32 (08) 2612-2618
    CrossrefPubMedGoogle Scholar
  • 11 Bednarek A, Atras A, Gągała J, Kozak Ł. Operative technique and results of core decompression and filling with bone grafts in the treatment of osteonecrosis of femoral head. Ortop Traumatol Rehabil 2010; 12 (06) 511-518
    PubMedGoogle Scholar
  • 12 Moher D, Liberati A, Tetzlaff J, Altman DG. PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Open Med 2009; 3 (03) e123-e130
    PubMedGoogle Scholar
  • 13 OCEBM Levels of Evidence—Centre for Evidence-Based Medicine (CEBM). University of Oxford. Accessed at: Accessed April 23, 2022 at: https://www.cebm.ox.ac.uk/resources/levels-of-evidence/ocebm-levels-of-evidence
    PubMedGoogle Scholar
  • 14 Gardeniers JWM. ARCO committee on terminology and staging (report on the committee meeting at Santiago De Compostela). ARCO Newslett 1993; 5: 79-82
    PubMedGoogle Scholar
  • 15 Steinberg ME. Diagnostic imaging and the role of stage and lesion size in determining outcome in osteonecrosis of the femoral head. Tech Orthop 2001; 16 (01) 6-15
    CrossrefPubMedGoogle Scholar
  • 16 Ficat RP. Idiopathic bone necrosis of the femoral head: early diagnosis and treatment. J Bone Joint Surg Br 1985; 67: 3-9
    CrossrefPubMedGoogle Scholar
  • 17 Civinini R, De Biase P, Carulli C. et al. The use of an injectable calcium sulphate/calcium phosphate bioceramic in the treatment of osteonecrosis of the femoral head. Int Orthop 2012; 36 (08) 1583-1588
    CrossrefPubMedGoogle Scholar
  • 18 Classen T, Warwas S, Jäger M, Landgraeber S. Two-year follow-up after advanced core decompression. J Tissue Eng Regen Med 2017; 11 (04) 1308-1314
    CrossrefPubMedGoogle Scholar
  • 19 Landgraeber S, Theysohn JM, Classen T. et al. Advanced core decompression, a new treatment option of avascular necrosis of the femoral head–a first follow-up. J Tissue Eng Regen Med 2013; 7 (11) 893-900
    CrossrefPubMedGoogle Scholar
  • 20 Liu P, Zhang QD, Wang Y. et al. One-stage total hip arthroplasty and “light-bulb” procedure for bilateral non-traumatic osteonecrosis of femoral head in different stages. Chin Med J (Engl) 2019; 132 (23) 2883-2885
    CrossrefPubMedGoogle Scholar
  • 21 Yu PA, Peng KT, Huang TW, Hsu RW, Hsu WH, Lee MS. Injectable synthetic bone graft substitute combined with core decompression in the treatment of advanced osteonecrosis of the femoral head: a 5-year follow-up. Biomed J 2015; 38 (03) 257-261
    CrossrefPubMedGoogle Scholar
  • 22 Landgraeber S, Tran TN, Claßen T. et al. Geometric analysis of an expandable reamer for treatment of avascular necrosis of the femoral head. Arch Orthop Trauma Surg 2015; 135 (10) 1357-1362
    CrossrefPubMedGoogle Scholar
  • 23 D'Ambrosi R, Biancardi E, Massari G, Ragone V, Facchini RM. Survival analysis after core decompression in association with platelet-rich plasma, mesenchymal stem cells, and synthetic bone graft in patients with osteonecrosis of the femoral head. Joints 2018; 6 (01) 16-22
    Article in Thieme ConnectPubMedGoogle Scholar
  • 24 Piuzzi NS, Anis HK, Muschler GF. Osteonecrosis of the femoral head with subchondral collapse. Cleve Clin J Med 2019; 86 (08) 511-512
    CrossrefPubMedGoogle Scholar
  • 25 Michael K-O, Kody B, Monti K. Algorithm for treatment of hip and knee osteonecrosis: review and a presentation of three example cases. J Rheum Dis Treat 2017; DOI: 10.23937/2469-5726/1510053.
    CrossrefPubMedGoogle Scholar
  • 26 Rocchi M, Del Piccolo N, Mazzotta A. et al. Core decompression with bone chips allograft in combination with fibrin platelet-rich plasma and concentrated autologous mesenchymal stromal cells, isolated from bone marrow: results for the treatment of avascular necrosis of the femoral head after 2 years minimum follow-up. Hip Int 2020; 30 (2_suppl, suppl): 3-12
    CrossrefPubMedGoogle Scholar
  • 27 Zhang L, Zhang J, Liang D. et al. Clinical study on minimally invasive treatment of femoral head necrosis with two different bone graft materials. Int Orthop 2021; 45 (03) 585-591
    CrossrefPubMedGoogle Scholar
  • 28 Li D, Xie X, Kang P, Shen B, Pei F, Wang C. Percutaneously drilling through femoral head and neck fenestration combining with compacted autograft for early femoral head necrosis: a retrospective study. J Orthop Sci 2017; 22 (06) 1060-1065
    CrossrefPubMedGoogle Scholar
  • 29 Kuroda Y, Nankaku M, Okuzu Y, Kawai T, Goto K, Matsuda S. Percutaneous autologous impaction bone graft for advanced femoral head osteonecrosis: a retrospective observational study of unsatisfactory short-term outcomes. J Orthop Surg Res 2021; 16 (01) 141
    CrossrefPubMedGoogle Scholar
  • 30 Jie K, Feng W, Li F. et al. Long-term survival and clinical outcomes of non-vascularized autologous and allogeneic fibular grafts are comparable for treating osteonecrosis of the femoral head. J Orthop Surg Res 2021; 16 (01) 109
    CrossrefPubMedGoogle Scholar
  • 31 Wei BF, Ge XH. Treatment of osteonecrosis of the femoral head with core decompression and bone grafting. Hip Int 2011; 21 (02) 206-210
    CrossrefPubMedGoogle Scholar